News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
238 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (164)
2 (249)
3 (156)
5 (7)
6 (230)
7 (240)
8 (320)
9 (291)
10 (99)
11 (2)
12 (4)
13 (247)
14 (235)
15 (231)
16 (238)
17 (128)
18 (5)
19 (4)
20 (183)
21 (221)
22 (223)
23 (239)
24 (116)
25 (4)
26 (4)
27 (246)
28 (244)
29 (262)
30 (310)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
FDA
FDA Gives UroGen’s Jelmyto Expedited Approval for Urothelial Cancer
Jelmyto is the first and only non-surgical treatment for patients with this indication. Here’s everything you need to know about it.
April 16, 2020
·
2 min read
·
Mark Terry
Policy
Elizabeth Holmes’ Fraud Case Delayed Until October Due to COVID-19 Concerns
On Wednesday, U.S. District Judge Edward Davila set a new date of Oct. 27 to hear the criminal fraud case against Holmes and Theranos’ former president and her former boyfriend, Ramesh “Sunny” Balwani.
April 16, 2020
·
3 min read
·
Alex Keown
Biotech Bay
Mammoth’s COVID-19 CRISPR-based Assay Validates Company’s Technology Approach
The Mammoth DETECTR assay was validated in less than two weeks and can deliver results in less than 45 minutes.
April 16, 2020
·
2 min read
·
Mark Terry
Business
Dynavax and Sinovac Partner to Develop COVID-19 Vaccine Candidate
The two companies will evaluate the combination of Sinovac’s chemically inactivated coronavirus vaccine candidate, with Dynavax’s advanced adjuvant, CpG 1018.
April 16, 2020
·
2 min read
·
Alex Keown
Business
BioSpace Movers & Shakers, April 17
Pharma and life sciences companies boost their executive ranks and boards with this week’s Movers & Shakers.
April 16, 2020
·
5 min read
·
Alex Keown
Drug Development
Biopharma Update on the Novel Coronavirus: April 16
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
April 16, 2020
·
8 min read
·
BioSpace Editorial Staff
Drug Development
Following Lab Test, Eagle Pharma Looks to Test MH Drug Ryanodex Against COVID-19
In a controlled laboratory test, Eagle Pharmaceuticals’ malignant hyperthermia treatment Ryanodex (dantrolene sodium) inhibited the growth of SARS-CoV-2, the virus causing the COVID-19 pandemic.
April 16, 2020
·
2 min read
·
Alex Keown
Drug Development
Research Roundup: Another Promising COVID-19 Vaccine and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
April 16, 2020
·
5 min read
·
Mark Terry
Career Advice
Savvy Prep for the New Normal: Online Job Interviews
Here’s how smart prospective interviewees can optimally prepare for success in online interviews.
April 16, 2020
·
4 min read
·
Katharine Hansen, PhD
Drug Development
Vir Shares Findings from Phase 1/2 Trial for VIR-2218 in Hepatitis B Virus
Data from the ongoing Phase II trial, as well as results from the Phase I trial of VR-2218, was released during a live webcast presentation on Wednesday.
April 16, 2020
·
2 min read
·
Michelle Brugioni
1 of 24
Next
